drugset / Trial / NCT01887223

Transconjunctival Needling Revision Versus Medical Treatment

NCT01887223

Phase 2 Completed 40 enrolled University of Sao Paulo General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

When the glaucoma filtering surgery failures (intraocular pressure rises again), the options is start to use the hypotensive eye drops again (medical treatment). However, in some cases (encapsulated blebs), there is a simple surgical revision that can revival the primary failure surgery. It calls transconjunctival needling revision. In this study, the investigators compare the efficacy of this revision versus medical treatment in 12-month follow up in eyes with encapsulated blebs.

Timeline

Start
2010-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule
Comparator Dorzolamide Small molecule
Comparator Latanoprost Small molecule
Comparator Timolol Other / unclassified 0.5 %

Indications